Possible treatment for hemophilia

Published Date: 13 Mar 2023

Hemophilia A is a rare bleeding disorder caused by a genetically encoded factor VIII mutation that affects blood clotting. sick...

Read Full News

Latest News

HER2-targeted radioimmunotherapy regimen achieves complete and durable response in breast cancer model

A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive breast cancer, according to new research published in the November issue of The Journal of Nuclear Medicine. ...

Combination immunotherapy helps overcome melanoma treatment resistance

Early data from a Phase 2 clinical trial show a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.

A toast to BRD4: How acidity changes the immune response

It started with wine. Or more precisely, a conversation about it. "My colleagues and I were talking about how some people think drinking wine may be anti-inflammatory," recalls Xu Zhou, Ph.D., from the Division of Gastroenterology, ...

Promising drug can inhibit aggressive breast cancer

New research reveals a drug developed by scientists at Oregon Health & Science University may develop into a new treatment for an especially aggressive form of breast cancer.

How colorectal cancer evades immunotherapy using a dual barrier

Colorectal cancer is one of the leading causes of cancer death worldwide. In recent years, immunotherapies—treatments that reactivate the immune system to attack tumor cells—have transformed the treatment of many types ...

Thunderstorms linked to surge in asthma ER visits

A new study finds that thunderstorms can trigger sharp increases in asthma-related emergency department (ED) visits, underscoring the importance of storm preparedness for people with asthma. The research is being presented ...

Todays Updates

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace

Bacteria are rapidly emerging as a new class of "living medicines" used to kill cancer cells.

New study elucidates obesity's role in fueling breast cancer progression

Obesity and cancer are two major health challenges of our time, yet the link between them remains only partially understood. New research now highlights a molecular chain of events in estrogen receptor-positive breast cancer, ...

Depression risk higher among long-term breast cancer survivors than women without breast cancer history

Long-term breast cancer survivors have a higher risk for developing depression, particularly if they have insomnia, according to a study published online Oct. 10 in SLEEPJ.

New imaging probe helps track prostate cancer and possibly treat it before resistance develops

Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a chemical imaging probe that resists the breakdown of certain compounds in the body, giving doctors a more dependable way ...

Todays Updates

How scientists are hacking bacteria to treat cancer, self-destruct, then vanish without a trace

Bacteria are rapidly emerging as a new class of "living medicines" used to kill cancer cells.

New study elucidates obesity's role in fueling breast cancer progression

Obesity and cancer are two major health challenges of our time, yet the link between them remains only partially understood. New research now highlights a molecular chain of events in estrogen receptor-positive breast cancer, ...

Depression risk higher among long-term breast cancer survivors than women without breast cancer history

Long-term breast cancer survivors have a higher risk for developing depression, particularly if they have insomnia, according to a study published online Oct. 10 in SLEEPJ.

New imaging probe helps track prostate cancer and possibly treat it before resistance develops

Researchers at Wayne State University and the Barbara Ann Karmanos Cancer Institute have developed a chemical imaging probe that resists the breakdown of certain compounds in the body, giving doctors a more dependable way ...

Latest News

A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive breast cancer, according to new research published in the November issue of The Journal of Nuclear Medicine. ...

Early data from a Phase 2 clinical trial show a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.

It started with wine. Or more precisely, a conversation about it. "My colleagues and I were talking about how some people think drinking wine may be anti-inflammatory," recalls Xu Zhou, Ph.D., from the Division of Gastroenterology, ...

New research reveals a drug developed by scientists at Oregon Health & Science University may develop into a new treatment for an especially aggressive form of breast cancer.

Colorectal cancer is one of the leading causes of cancer death worldwide. In recent years, immunotherapies—treatments that reactivate the immune system to attack tumor cells—have transformed the treatment of many types ...

A new study finds that thunderstorms can trigger sharp increases in asthma-related emergency department (ED) visits, underscoring the importance of storm preparedness for people with asthma. The research is being presented ...

News All Time

Multidimensional map shows how the brain develops—and how it resolves inflammation

Researchers at Karolinska Institutet and Yale University have created a multidimensional, molecular map of how the mouse brain develops after birth and how it reacts to inflammation. The study, which is published in Nature, ...

Study finds promising first evidence of targeted therapy for NRAS-mutant melanoma

New research from Moffitt Cancer Center shows that RAS(ON) multi-selective inhibition can directly block tumor growth and activate the immune system, offering the first targeted approach for patients with NRAS-mutant melanoma, ...

Why cancer immunotherapy isn't effective for everyone

A study led by André Veillette, a researcher at the Montreal Clinical Research Institute (IRCM) and a professor in the Faculty of Medicine at University of Montreal, sheds new light on the complexity of the immune system ...

Macrophage 'bodyguard' disruptors may help overcome hormone-resistant breast cancer

In preclinical studies, researchers at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, have tested a new combination therapy for hormone-resistant, estrogen receptor-positive ...

Certain p53 mutations may make tumors more vulnerable to immunotherapy

The gene p53 acts as a tumor suppressor and is often called the guardian of the genome. This gene is central to maintaining genomic stability, which prevents mutations from accumulating and leading to cancer. But when p53 ...

Sugars on immune cells, not just blood vessel walls, may regulate the inflammatory disease process

New research has updated the understanding of how sugars, known as glycans, help immune cells move into the skin in the inflammatory disease, psoriasis.

Nerve injuries can affect the entire immune system, study finds

Nerve injuries can have long-lasting effects on the immune system that appear to differ between males and females, according to preclinical research from McGill University.

From blood to solid tumors: A new way to power up CAR T cell therapy

Chimeric Antigen Receptor (CAR) T cell therapies have revolutionized cancer treatment—but so far, their success has been largely limited to blood cancers. Solid tumors, which account for around 90% of all adult cancers, ...

Poison ivy, poison oak and poison sumac rash

When skin touches poison ivy, poison oak or poison sumac plants, the oils from the plant can cause a rash. This rash can be very uncomfortable, itchy and unsightly. The medical name for this rash is contact dermatitis. Since ...

People abused by intimate partners have worse asthma—researchers are still investigating this surprising link

Asthma is a common, serious and difficult-to-manage chronic health condition. In the U.S., 1 in 7 people are diagnosed with asthma, and that number is rising.

Antibody therapy foils pancreatic cancer's sugar-based disguise to reawaken immune system

Pancreatic cancer is notoriously hard to treat and often resists the most advanced immunotherapies. Northwestern Medicine scientists have uncovered a novel explanation for that resistance: Pancreatic tumors use a sugar-based ...

Immunotherapy resistance in kidney cancer driven by myeloid cell signaling

Immunotherapy with immune checkpoint inhibitors is standard first-line treatment for advanced renal cell carcinoma (RCC), but not every patient responds.

Turning on an immune pathway in tumors could lead to their destruction

By stimulating cancer cells to produce a molecule that activates a signaling pathway in nearby immune cells, MIT researchers have found a way to force tumors to trigger their own destruction.

VEXAS syndrome research reveals overactive bone marrow stem cells may drive inflammation

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have developed some of the first robust laboratory models of a confounding adult-onset inflammatory disease called VEXAS syndrome—shedding new light on its mechanisms ...

DNA copy-number changes help melanoma develop resistance to immunotherapy, study finds

A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators reveals how melanoma, the deadliest form of skin cancer, evolves to resist immunotherapy and identifies a potential strategy to prevent or reverse ...

Researchers unravel mystery behind rare pregnancy disorder

Leiden researchers have found clues to why a rare pregnancy disorder is mild in some babies but life-threatening in others. Their discovery opens the door to a test that could identify severe cases during pregnancy. Fortunately, ...

Recommended News For You

Colorectal Cancer Screening Uptake Tripled in 45-49 Age Group

Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.

Researchers discover cellular 'doorway' exploited by cancer-causing virus

Screening for prostate cancer: is it time to give up digital rectal examination?

First-Line HCC Trial's Lenvatinib-Pembrolizumab Combo Misses Target.

'Sugar' signatures help identify and classify pancreatic cancer cell subtypes

Immunotherapy after surgery is good for patients with advanced cancer

Recommended Articles For You

Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights 

Uncovering the Mystery of the Sessile Serrated Adenoma 

Neoadjuvant Abraxane Chemotherapy Combined with Neutrophil Cytopharmaceuticals and Radiotherapy 

Understanding the Role of CA 19-9 in Cancer Diagnosis and Treatment 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chromatin organization linked to p53 tumor suppression mechanism

2.

Study: Pre-operative THP leads to pCR in 64% of early-stage HER2+ ER- breast cancer patients

3.

Cancer After Weight Loss; How Older Adults Use the Healthcare System.

4.

Patients face high out-of-pocket costs after incident cancer diagnosis

5.

In R/R Follicular Lymphoma, Tisa-Cel Produces Long-Lasting Responses.

1.

Breaking Down the Different Types of Lymphoma: What You Need to Know 

2.

HPV and Immunotherapy in Cancer Survivorship: National Cancer Survivors Day Review

3.

Glycopyrrolate: The Secret Weapon for Excessive Sweating 

4.

Using Node Technology to Fight Breast Cancer: A New Hope for Early Detection

5.

Unlocking the Potential of Etoposide: A Novel Approach to Cancer Treatment

1.

International Lung Cancer Congress®

2.

Future NRG Oncology Meeting

3.

Genito-Urinary Oncology Summit 2026

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

2.

Navigating the Complexities of Ph Negative ALL - Part XIV

3.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII

5.

Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot